"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to a study published online in Neurology.

COVID-19 infection is not associated with immediate changes in multiple sclerosis symptom severity or disability.

Third, clear accountability and reporting standards are essential. Regulatory frameworks must include incentives for financial services institutions to disclose their progress on universal inclusion ...

A team of doctors in Mumbai treated a 24-year-old engineering student who was suffering from multiple sclerosis, a chronic disease that affects the nervous system. For the patient, Sushant Chavan, ...

After getting through a significant difficulty, many of us reject being described in favorable terms. Why don't we want to ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...

The average wait time between a referral and neurologist visit was more than a month among older adults, with longer wait ...

Saad Z. Usmani, MD, MBA, FACP, discusses how the definition of the transplant-ineligible population for multiple myeloma is evolving while also addressing the challenges of standardizing minimal ...

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage ...